AB

Ajay Bikram Singh

Active Director Director DIN 10236145
DIN 10236145 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Ajay Bikram Singh

Data last updated:

Ajay Bikram Singh is a Director at Achmedico Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Achmedico Pharmaceuticals Private Limited reported revenue of ₹82,450 (FY 2024).

DIN 10236145
Primary Designation Director
Industry Pharma
First Appointment 12 Jul 2023
Oldest Company Age 3 yrs
Largest company Achmedico Pharmaceuticals Private Limited · ₹82,450 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jul 20232023₹82,450 (FY 2024)Active

Board colleagues of Ajay Bikram Singh

NameDINCompanyDesignation
Chandra Mohan Jha09833670Achmedico Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Achmedico Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ajay Bikram Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Bikram Singh

Ajay Bikram Singh currently holds 1 directorship: Achmedico Pharmaceuticals Private Limited (Director, since 12 Jul 2023, revenue ₹82,450 (FY 2024)).

Ajay Bikram Singh was first appointed on 12 Jul 2023 as Director at Achmedico Pharmaceuticals Private Limited.

The current boards of Ajay Bikram Singh's companies include Chandra Mohan Jha (Achmedico Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available